Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LEGN |
---|---|---|
09:32 ET | 21246 | 56.285 |
09:34 ET | 9039 | 55.86 |
09:36 ET | 5635 | 56 |
09:38 ET | 15454 | 56.0234 |
09:39 ET | 4420 | 56.185 |
09:41 ET | 6057 | 56.48 |
09:43 ET | 36938 | 56.3 |
09:45 ET | 100306 | 56.465 |
09:48 ET | 81300 | 56.24 |
09:50 ET | 10128 | 56.37 |
09:52 ET | 2984 | 56.415 |
09:54 ET | 32872 | 56.26 |
09:56 ET | 14236 | 56.41 |
09:57 ET | 2461 | 56.415 |
09:59 ET | 151076 | 56.15 |
10:01 ET | 90682 | 55.9325 |
10:03 ET | 7614 | 56.31 |
10:06 ET | 5300 | 56.34 |
10:08 ET | 8395 | 56.11 |
10:10 ET | 4988 | 56 |
10:12 ET | 30075 | 55.82 |
10:14 ET | 99581 | 56.09 |
10:15 ET | 2628 | 56.14 |
10:17 ET | 6720 | 55.84 |
10:19 ET | 9789 | 55.7201 |
10:21 ET | 1402 | 56.05 |
10:24 ET | 85312 | 55.94 |
10:26 ET | 9025 | 55.96 |
10:28 ET | 1200 | 55.84 |
10:30 ET | 16409 | 55.59 |
10:32 ET | 3500 | 55.385 |
10:33 ET | 5525 | 55.21 |
10:35 ET | 14652 | 55.39 |
10:37 ET | 5268 | 55.095 |
10:39 ET | 8127 | 55.15 |
10:42 ET | 5184 | 55.1 |
10:44 ET | 7512 | 55.17 |
10:46 ET | 7336 | 55.295 |
10:48 ET | 156003 | 55.145 |
10:50 ET | 23973 | 54.82 |
10:51 ET | 5040 | 54.96 |
10:53 ET | 12917 | 54.66 |
10:55 ET | 14264 | 54.58 |
10:57 ET | 33894 | 54.76 |
11:00 ET | 33246 | 55.075 |
11:02 ET | 2236 | 55.16 |
11:04 ET | 4768 | 55.27 |
11:06 ET | 900 | 55.2975 |
11:08 ET | 2920 | 55.56 |
11:09 ET | 2700 | 55.84 |
11:11 ET | 3350 | 55.905 |
11:13 ET | 4369 | 55.54 |
11:15 ET | 2063 | 55.8 |
11:18 ET | 1000 | 55.77 |
11:20 ET | 4768 | 55.8 |
11:22 ET | 340 | 55.72 |
11:24 ET | 2650 | 55.52 |
11:26 ET | 1550 | 55.575 |
11:27 ET | 14570 | 55.3 |
11:29 ET | 1000 | 55.255 |
11:31 ET | 3007 | 55 |
11:33 ET | 6844 | 54.975 |
11:36 ET | 741 | 55.02 |
11:38 ET | 1580 | 55.23 |
11:40 ET | 1900 | 55.21 |
11:42 ET | 1477 | 55.19 |
11:44 ET | 2275 | 55.23 |
11:45 ET | 10821 | 55.03 |
11:47 ET | 2100 | 55.095 |
11:49 ET | 1000 | 55.02 |
11:51 ET | 300 | 55.02 |
11:54 ET | 6819 | 55.07 |
11:56 ET | 920 | 55.085 |
11:58 ET | 2899 | 55.15 |
12:00 ET | 2900 | 55.255 |
12:02 ET | 1601 | 55.365 |
12:03 ET | 870 | 55.375 |
12:05 ET | 2077 | 55.38 |
12:07 ET | 5082 | 55.135 |
12:09 ET | 900 | 55.07 |
12:12 ET | 600 | 55.03 |
12:14 ET | 2353 | 55.12 |
12:16 ET | 815 | 55.15 |
12:18 ET | 1531 | 55.24 |
12:20 ET | 3189 | 55.34 |
12:21 ET | 9557 | 55.25 |
12:23 ET | 7505 | 55.29 |
12:25 ET | 8933 | 55.15 |
12:27 ET | 115 | 55.19 |
12:30 ET | 2316 | 55.185 |
12:32 ET | 1600 | 55.15 |
12:34 ET | 8484 | 55.24 |
12:36 ET | 1200 | 55.27 |
12:38 ET | 800 | 55.275 |
12:39 ET | 1500 | 55.295 |
12:41 ET | 3299 | 55.28 |
12:43 ET | 3217 | 55.23 |
12:45 ET | 4351 | 55.29 |
12:48 ET | 1992 | 55.33 |
12:50 ET | 2037 | 55.325 |
12:52 ET | 6867 | 55.21 |
12:54 ET | 2400 | 55.265 |
12:56 ET | 1100 | 55.37 |
12:57 ET | 413 | 55.34 |
12:59 ET | 1332 | 55.41 |
01:01 ET | 1330 | 55.32 |
01:03 ET | 3100 | 55.18 |
01:06 ET | 5230 | 55.12 |
01:08 ET | 3200 | 55.17 |
01:12 ET | 381 | 55.205 |
01:14 ET | 1600 | 55.18 |
01:15 ET | 2963 | 55.24 |
01:17 ET | 1976 | 55.25 |
01:19 ET | 1818 | 55.18 |
01:21 ET | 3618 | 55.24 |
01:24 ET | 5085 | 55.18 |
01:26 ET | 1300 | 55.235 |
01:28 ET | 800 | 55.29 |
01:30 ET | 1000 | 55.26 |
01:32 ET | 2250 | 55.17 |
01:33 ET | 3746 | 55.19 |
01:35 ET | 2347 | 55.2 |
01:37 ET | 6264 | 55.32 |
01:39 ET | 2281 | 55.27 |
01:42 ET | 3500 | 55.33 |
01:44 ET | 2780 | 55.38 |
01:46 ET | 948 | 55.32 |
01:48 ET | 2611 | 55.29 |
01:50 ET | 300 | 55.26 |
01:51 ET | 1800 | 55.16 |
01:53 ET | 1012 | 55.17 |
01:55 ET | 1645 | 55.15 |
01:57 ET | 8696 | 55.28 |
02:00 ET | 1293 | 55.335 |
02:02 ET | 986 | 55.37 |
02:04 ET | 5343 | 55.325 |
02:06 ET | 3509 | 55.285 |
02:08 ET | 46115 | 55.23 |
02:09 ET | 9689 | 55.16 |
02:11 ET | 6702 | 55.37 |
02:13 ET | 4282 | 55.46 |
02:15 ET | 300 | 55.505 |
02:18 ET | 11695 | 55.69 |
02:20 ET | 577 | 55.75 |
02:22 ET | 500 | 55.68 |
02:24 ET | 700 | 55.71 |
02:26 ET | 2187 | 55.68 |
02:27 ET | 6192 | 55.72 |
02:31 ET | 633 | 55.69 |
02:33 ET | 7849 | 55.665 |
02:36 ET | 1500 | 55.67 |
02:38 ET | 950 | 55.6 |
02:40 ET | 1079 | 55.54 |
02:42 ET | 2334 | 55.46 |
02:44 ET | 1450 | 55.35 |
02:45 ET | 1150 | 55.43 |
02:47 ET | 3107 | 55.35 |
02:49 ET | 3836 | 55.315 |
02:51 ET | 4200 | 55.365 |
02:54 ET | 1616 | 55.34 |
02:56 ET | 1420 | 55.365 |
02:58 ET | 1400 | 55.415 |
03:00 ET | 2607 | 55.36 |
03:02 ET | 3770 | 55.34 |
03:03 ET | 612 | 55.31 |
03:05 ET | 2000 | 55.19 |
03:07 ET | 1100 | 55.13 |
03:09 ET | 3420 | 55.16 |
03:12 ET | 1420 | 55.225 |
03:14 ET | 11371 | 54.96 |
03:16 ET | 968 | 54.86 |
03:18 ET | 3700 | 54.92 |
03:20 ET | 3744 | 55 |
03:21 ET | 3420 | 54.97 |
03:23 ET | 1709 | 55.01 |
03:25 ET | 35599 | 54.97 |
03:27 ET | 5515 | 55.03 |
03:30 ET | 7231 | 55.13 |
03:32 ET | 5520 | 55.295 |
03:34 ET | 4893 | 55.2 |
03:36 ET | 3527 | 55.235 |
03:38 ET | 25622 | 55.39 |
03:39 ET | 4932 | 55.43 |
03:41 ET | 13850 | 55.21 |
03:43 ET | 2998 | 55.12 |
03:45 ET | 1084 | 55.11 |
03:48 ET | 10105 | 55.16 |
03:50 ET | 3950 | 55.15 |
03:52 ET | 14704 | 55.2175 |
03:54 ET | 16307 | 55.41 |
03:56 ET | 28147 | 55.115 |
03:57 ET | 26825 | 55.16 |
03:59 ET | 48684 | 55 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Legend Biotech Corp | 10.0B | -21.1x | --- |
Ascendis Pharma A/S | 8.1B | -14.3x | --- |
Insmed Inc | 12.3B | -14.4x | --- |
Blueprint Medicines Corp | 7.2B | -23.7x | --- |
Vaxcyte Inc | 8.9B | -19.3x | --- |
Intra-Cellular Therapies Inc | 8.1B | -66.4x | --- |
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $10.0B |
---|---|
Revenue (TTM) | $342.8M |
Shares Outstanding | 182.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.16 |
EPS | $-2.60 |
Book Value | $6.88 |
P/E Ratio | -21.1x |
Price/Sales (TTM) | 29.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -157.97% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.